Lung Microbiota Influence Responses to Anti-PD1 Therapy in a Preclinical Model of Non-small Cell Lung Cancer

被引：0
|
作者：
Chang, M. [1 ]
Mccormick, C. [1 ]
Kwok, B. [2 ]
Li, Y. [3 ]
Kyeremateng, Y. [1 ]
Aktas, A. [4 ]
Singh, R. [1 ]
Singh, S. [5 ]
Li, Q. [6 ]
Kugler, M. C. [7 ]
Pass, H. [8 ]
Sterman, D. H. [9 ]
Wu, B. G. [10 ]
Segal, L. N. [3 ]
Tsay, J. J. [11 ]
机构：
[1] NYU Langone Hlth, New York, NY USA
[2] NYU, New York, NY USA
[3] NYU, Sch Med, Med, New York, NY USA
[4] Vet Affairs New York Harbor Healthcare Syst, Med, New York, NY USA
[5] NYU, Sch Med, Pulm & Crit Care Med, New York, NY USA
[6] NYU, Sch Med, Div Pulm & Crit Care Med, New York, NY USA
[7] New York Univ Hosp Ctr, Med, New York, NY USA
[8] NYU Langone Hlth, Bronxville, NY USA
[9] NYU, Sch Med, NYU Langone Med Ctr, New York, NY USA
[10] Dept Internal Med, Div Pulm Crit Care & Sleep Med, New York, NY USA
[11] NYU, Sch Med, Pulm Crit Care, New York, NY USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6691
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Imaging of Anti-PD1 Therapy Response in Advanced Non-Small Lung Cancer
    Katz, Sharyn
    Hammer, Mark
    Bagley, Stephen
    Aggarwal, Charu
    Bauml, Joshua
    Langer, Corey
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S553 - S554
  • [2] Resistance mechanisms in non-small cell lung cancer patients upon anti-PD1 therapy
    Hiltbrunner, S.
    Cords, L.
    Kasser, S.
    Freiberger, S.
    Kreutzer, S.
    Toussaint, N.
    Grob, L.
    Bihr, S.
    Rechsteiner, M.
    Soltermann, A.
    Bodenmiller, B.
    Curioni-Fontecedro, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 195 - 195
  • [3] What is the optimal duration, dose and frequency for anti-PD1 therapy of non-small cell lung cancer?
    Kuah, Chii Yang
    Monfries, Robert
    Quartagno, Matteo
    Seckl, Michael J.
    Ghorani, Ehsan
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [4] CD155 expression impairs anti-PD1 therapy response in non-small cell lung cancer
    Jiang, Chang
    Qu, Xiaodie
    Ma, Li
    Yi, Ling
    Cheng, Xu
    Gao, Xiang
    Wang, Jinghui
    Che, Nanying
    Zhang, Hongtao
    Zhang, Shucai
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2022, 208 (02): : 220 - 232
  • [5] Efficacy and Safety of Addition of Anti-PD1 to Chemotherapy in Treatment of Non-Small Cell Lung Cancer
    Ru, Chu-Hui
    Zhuang, Yan-Bing
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2018, 21 (10) : 711 - 717
  • [6] Soluble immune biomarkers to anti-PD1 treatment in non-small cell lung cancer (NSCLC)
    Garde-Noguera, J.
    Jantus-Lewintre, E.
    Honrubia Peris, B.
    Gallach Garcia, S.
    Zhang, F.
    Garcia Sanchez, J.
    Calabuig Farinas, S.
    Blasco Cordellat, A.
    Piera Molons, N.
    Vidal-Martinez, J.
    Murado-Pardo, J.
    Condori Farfan, L. D.
    Gisbert-Criado, R.
    Escorihuela, E.
    Camps, C.
    ANNALS OF ONCOLOGY, 2018, 29
  • [7] Cytokine profiles of peripheral blood in patients with non-small cell lung cancer receiving anti-PD1 therapy.
    Teplyakova, Maria A.
    Vladimirova, Liubov Yu
    Popova, Irina L.
    Lyanova, Aza A.
    Abramova, Natalia A.
    Storozhakova, Anna E.
    Ryadinskaya, Ludmila A.
    Tikhanovskaya, Natalia M.
    Udalenkova, Irina A.
    Kalabanova, Elena A.
    Kabanov, Sergey N.
    Sagakyants, Aleksandr B.
    Zlatnik, Elena Yu
    Shulgina, Oksana G.
    Zolotareva, Ekaterina I.
    Ulianova, Elena P.
    Kecheryukova, Takhmina M.
    Sergeeva, Marina M.
    Lazutin, Yuriy N.
    Kharagezov, Dmitry A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [8] Neutrophil/Lyrnphocyte Ratio in Advanced Non-Small Cell Lung Cancer: Correlation with Prognosis and Response to Anti-PD1 Therapy
    Galata, Domenico
    Logroscino, Antonio Fabio
    Misino, Andrea
    Montagna, Elisabetta Sara
    Petrillo, Patrizia
    Ricci, Donata
    Catino, Annamaria
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1329 - S1330
  • [9] Complete response to anti-PD1 therapy and chemotherapy in a patient with ALK-rearranged non-small cell lung cancer
    Hu, Haoyue
    Min, Min
    Dai, Hongchun
    Tang, Youpan
    He, Jun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2025, 18 (01): : 37 - 41
  • [10] A rationale for surgical debulking to improve anti-PD1 therapy outcome in non small cell lung cancer
    Guisier, Florian
    Cousse, Stephanie
    Jeanvoine, Mathilde
    Thiberville, Luc
    Salaun, Mathieu
    SCIENTIFIC REPORTS, 2019, 9 (1)
12345